Related Experiment Video
Updated: Apr 12, 2026

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
Arrhythmias in Fabry cardiomyopathy
Deepak Acharya1, Harish Doppalapudi2, José A Tallaj1
1Section of Advanced Heart Failure and Transplant Cardiology, Division of Cardiovascular Diseases, University of Alabama at Birmingham, 1900 University Boulevard, THT 321, Birmingham, AL 35294, USA.
Fabry disease, a genetic disorder, causes severe cardiac issues like arrhythmias and heart failure due to enzyme deficiency. Enzyme replacement therapy and devices like pacemakers improve outcomes for affected patients.
Area of Science:
- Cardiology
- Genetics
- Metabolic Disorders
Background:
- Fabry disease is an X-linked genetic disorder resulting from α-galactosidase A enzyme deficiency.
- This deficiency leads to glycolipid accumulation, impacting multiple organ systems, notably the cardiovascular system.
Purpose of the Study:
- To outline the cardiovascular manifestations of Fabry disease.
- To discuss the mechanisms underlying cardiac dysfunction in Fabry disease.
- To review current therapeutic strategies for managing cardiac complications.
Main Methods:
- Review of existing literature on Fabry disease and its cardiac effects.
- Analysis of pathophysiological mechanisms of glycolipid accumulation in cardiac tissues.
- Evaluation of treatment outcomes for enzyme replacement therapy and device implantation.
Main Results:
- Cardiovascular issues in Fabry disease include hypertension, coronary artery disease, arrhythmias, valvular problems, heart failure, and sudden death.
- Bradycardia and conduction abnormalities stem from glycolipid buildup in cardiac conduction tissues.
- Cardiac hypertrophy and fibrosis create a basis for persistent arrhythmias and potential sudden cardiac death.
Conclusions:
- Fabry disease presents significant cardiovascular risks, including life-threatening arrhythmias and heart failure.
- Enzyme replacement therapy offers potential for improved cardiac function and clinical outcomes.
- Pacemakers and defibrillators are crucial for managing arrhythmia risk in patients with Fabry disease.
More Related Videos
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias

